BCL6 and cancer: Cancer-associated mutant forms of FBW7β (R385H and R385C) corresponding to FBW7α (R465H and R465C) [11, 28] displayed a reduced ability to promote BCL6 degradation (Fig. S9A, B, Supporting Information).